1-Dehydro-6-gingerdione

CAS No. 76060-35-0

1-Dehydro-6-gingerdione( —— )

Catalog No. M31246 CAS No. 76060-35-0

1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    1-Dehydro-6-gingerdione
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.
  • Description
    1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.
  • In Vitro
    6-Dehydrogingerdione could trigger apoptotic cell death via both mitochondrial- and Fas receptor-mediated pathways.6-Dehydrogingerdione (6-DG) up-regulates Ser-15 phosphorylation and evoked p53 nuclear translocation.6-Dehydrogingerdione (6-DG) induces mitochondrial apoptotic pathway. Apoptosis Analysis Cell Line:Hep G2 cells.Concentration:0, 50, 100 μM.Incubation Time:24 h.Result:Induced Apoptosis in Hep G2 Cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    76060-35-0
  • Formula Weight
    290.4
  • Molecular Formula
    C17H22O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neuromedin (U25), hu...

    Neuromedin U-25 human is the active form of neuromedin U in human. Neuromedin U-25 human inhibits glucose-stimulated insulin secretion, which leads to early-onset obesity. Neuromedin U-25 serves as vasoconstrictor in human vascular beds.

  • Guibourtinidin chlor...

    Reference standards.

  • Cixutumumab

    Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling.